CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Fentanyl Citrate

Last Updated: August 22, 2011
Result type: Reports
Project Number: SR0248-000
Product Line: Reimbursement Review

Generic Name: Fentanyl Citrate

Brand Name: Onsolis

Manufacturer: Meda Valeant Pharma Canada Inc.

Therapeutic Area: Pain, breakthrough cancer pain

Indications: Pain (breakthrough), cancer (adults)

Submission Type: Resubmission

Project Status: Complete

Date Recommendation Issued: February 15, 2012

Recommendation Type: Do not list